Investor alert: pomerantz law firm announces the filing of a class action against regeneron pharmaceuticals, inc. - regn

New york , feb. 18, 2025 /prnewswire/ -- pomerantz llp announces that a class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn).  such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-pomlaw), toll-free, ext.
REGN Ratings Summary
REGN Quant Ranking